Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial
Fariba Yarandi, Azamsadat Mousavi, Fereshteh Abbaslu, Soheila Aminimoghaddam, Sepideh Nekuie, Khadijeh Adabi, Parviz Hanjani
International Journal of Gynecologic Cancer Jun 2016, 26 (5) 971-976; DOI: 10.1097/IGC.0000000000000687